MarketLine - Exelixis Inc. (EXEL) Exelixis, Inc. â€“ Mergers Acquisitions (MA), Partnerships Alliances and Investment Report

Report

MarketLine

MarketLine Department

EUR 311.72 For Business Accounts Only

Exelixis, Inc. â€“ Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary
Pharmaceuticals and Healthcare

Key Findings
Pharmaceuticals and Healthcare

Pharmaceuticals and Healthcare

Reasons To Buys
MarketLine

Key Highlights
United States

14/06/2017 74 EN

Underlying

Exelixis Inc.

Exelixis is an oncology-focused biotechnology company that involved in the discovery, development and commercialization of new medicines for cancers. The company's marketd products are: CABOMETYX? (cabozantinib) tablets for renal cell carcinoma and previously treated hepatocellular carcinoma; and COMETRIQ? (cabozantinib) capsules for progressive, metastatic medullary thyroid cancer. The company's products resulting from its discovery efforts are: COTELLIC? (cobimetinib), an inhibitor of MEK approved as part of a combination regimen to treat melanoma; and MINNEBRO? (esaxerenone), an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension in Japan.

See profile

US30161Q1040 NASDAQ Stock Market United States

Provider

MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

MarketLine’ holistic business intelligence report collection includes:

Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

See profile

Analysts

MarketLine Department

Other Reports on these Companies

Vermilion Research

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 42.64

June 30, 2025 June 30, 2025 1 EN

Vermilion Research

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

EUR 42.64

May 17, 2024 May 17, 2024 1 EN

Vermilion Research

Vermilion Compass: Weekly Equity Strategy

Upgrading Staples and Health Care to Market Weight As the saying goes, "sector rotation is the lifeblood of a bull market." That appears to be exactly what is going on as we kick off 2024. Leadership areas that have significantly outperformed since the October 2023 lows are starting to pull back rather hard -- and on above average volume. This includes areas such as Technology (XLK), semiconductors (SMH), software (IGV), and the ARKK, IPO, and BITQ ETFs. This tells us a pause/pullback is likely for these high-octane areas, where technicals are short-term bearish, but still bullish longer-term...

EUR 42.64

January 3, 2024 January 3, 2024 1 EN

Hargreaves Lansdown Ltd - Company Profile and SWOT Analysis

Summary Hargreaves Lansdown Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Hargreaves Lansdown Ltd (HLP) is a UK-based investment management company. The company's primary activities involve providing a platform for private investors to manage their investments and pensions. HLP offers a wide range of investment options, including funds, shares, bonds, and gilts, alo...

EUR 149.22

August 21, 2025 August 21, 2025 1 EN

MarketLine Department

MarketLine Department

Elbit Systems Ltd - Company Profile and SWOT Analysis

Summary Elbit Systems Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Elbit Systems Ltd (Elbit Systems) designs and develops systems and equipment for aerospace and command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR). The company offers advanced electro-optics and countermeasures systems, unmanned aircraft systems (UAS) ...

EUR 149.22

August 21, 2025 August 21, 2025 1 EN

MarketLine Department

MarketLine Department

Sunway REIT Management Sdn Bhd - Company Profile and SWOT Analysis

Summary Sunway REIT Management Sdn Bhd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Sunway REIT Management Sdn Bhd (Sunway REIT) is a real estate investment trust in Malaysia. It carries out investment and acquisition of commercial properties such as retail and mixed-use; high-growth cities and townships; and office, hospitals, and hotel properties. It also provides ma...

EUR 149.22

August 21, 2025 August 21, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Exelixis, Inc. â€“ Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Vital Signs: Actionable charts

Vermilion Short Shots: Technically Vulnerable Stocks

Vermilion Compass: Weekly Equity Strategy

Hargreaves Lansdown Ltd - Company Profile and SWOT Analysis

Elbit Systems Ltd - Company Profile and SWOT Analysis

Sunway REIT Management Sdn Bhd - Company Profile and SWOT Analysis

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe